Negatively charged cell surface components

Negatively charged cell surface components encompass a diverse array of molecules including sialic acid-containing glycoproteins, glycosaminoglycans like heparan sulfate, and anionic phospholipids such as phosphatidylserine or lipopolysaccharides in bacteria. These components create an overall negative surface charge (zeta potential) that is critical for maintaining the structural integrity of the glycocalyx and regulating molecular trafficking at the cell-environment interface. In healthy mammalian cells, these charges facilitate cell-cell recognition and prevent non-specific aggregation, whereas in many pathogens and cancer cells, the density and composition of these charges are altered to evade the immune system or enhance attachment. Therapeutic strategies targeting these components often rely on cationic molecules, such as polymyxins or antimicrobial peptides, which bind via electrostatic interactions to disrupt microbial membranes or block viral entry. However, the broad distribution of these anionic features across various tissues presents significant challenges for achieving high drug selectivity and minimizing off-target toxicities.

Other names

Anionic cell surfaceCell surface anionsNegatively charged membrane componentsAnionic glycocalyxSurface polyanions

Drugs typically utilize electrostatic attraction to bind these components, leading to membrane permeabilization, displacement of essential divalent cations, or inhibition of viral/bacterial attachment to host cells.